Semaglutide and Type 2 Diabetes
Contact Hours: 2
Pharmacology Hours: 2
What's included?
Course Overview
In 2017, the FDA approved the use of semaglutide injectable (Ozempic) in the treatment of type 2 diabetes. The drug has experienced widespread acceptance due to its positive effects on weight loss and lowering of chronic health risks. The drug has risen in popularity over the past few years, as many well-known actors/actresses/songwriters, and more came forward, publicly sharing their weight loss journey.
This rise in popularity has also resulted in significant shortages of this medication, negatively impacting the lives of the diabetic community, local pharmacies, and healthcare providers. The goal of this continuing education program is to educate and empower the healthcare provider in all aspects of this drug regimen: clinical indications, patient education, cost options, and benefit/risk analysis.
Course Outline
- Introduction
- Diabetes Overview
- Types of Diabetes
- Diabetes Signs and Symptoms, Diagnostic Testing
- Semaglutide
- What is meant by receptor agonist and antagonist?
- Side Effects of Semaglutide
- Dosing
- Prescribing insights: Long-Term therapy for a chronic condition?
- Cost Concerns
- Emerging Concerns: Semaglutide and gastroparesis
- Diabetes and gastroparesis
- Diabetes Lifestyle changes: Patient education (16)
Course Outcomes
After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:
- Describe the action of non-insulin injectable diabetes medication semaglutide.
- Identify patient-specific contraindications for this medication.
- Discuss the long-term use of semaglutide injectables specific to the treatment of type 2 diabetes.
Accreditations and Approvals
- American Nurses Credentialing Center (ANCC) (P0614)
- California Board of Registered Nursing (CEP 17418)
- Kentucky Board of Nursing (7-0090)
- Louisiana State Board of Nursing (58)
- Florida Board of Nursing (50-23983)
- Delaware Board of Nursing (DE-24-010127)
- Alabama Board of Nursing (#ABNP1577)
- Iowa Board of Nursing (#393)
- Kansas Board of Nursing (LT0340-0325)
Approved by the Board of Nursing in every state, you can complete your RN, LVN, and APRN CEUs with confidence.
Accreditation Statement
Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.
Written For
- Advanced Practice Registered Nurses (APRN)
Requirements for Completion
- Enrollment in the course by the learner
- Read and learn all course materials
- Complete the course evaluation
- Attest and testify learning of the course materials
Disclosure of Relevant Financial Relationships
Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.
